Insider trades
Christopher Patusky, Director of United Therapeutics UTHR, has filed 5 purchases and 25 sales on the open market. Over the past 12 months that comes to a net sale of $2.7M. The latest trade was on 04/24.
Christopher Patusky
Director
- Company
- United Therapeutics UTHR
- First filing
- 23/01/04
- Trades
- 73 trades
- Buys / sales
- 5 / 25
- 12-month net buying
- −$2.7M
- Last trade
- 04/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 04/24 | 04/24 | 2,910 sh | $569.00 | $1,655,790 | −66.1% | |
| Open-market sale10b5-1 plan | 04/17 | 04/17 | 1,000 sh | $578.88 | $578,880 | −40.2% | |
| Open-market sale | 25/12/15 | 25/12/16 | 1,000 sh | $495.95 | $495,950 | −40.2% | |
UTHR | Open-market sale10b5-1 plan | 25/03/19 | 25/03/20 | 5,000 sh7 trades | $310.72avg. | $1,553,585.42 | −84.7% |
UTHR | Open-market sale10b5-1 plan | 25/01/10 | 25/01/13 | 5,000 sh6 trades | $361.61avg. | $1,808,054.8 | −84.7% |
UTHR | Open-market sale | 24/09/03–24/09/04 | 24/09/05 | 5,000 sh2 trades | $354.33avg. | $1,771,665 | −84.7% |
| Open-market sale | 24/06/17 | 24/06/18 | 2,000 sh | $295.50 | $591,000 | −100.0% | |
| Open-market sale | 24/05/14 | 24/05/15 | 1,310 sh | $264.35 | $346,298.5 | −100.0% | |
| Open-market sale | 24/02/23 | 24/02/26 | 1,680 sh | $224.00 | $376,320 | −99.8% | |
UTHR | Open-market buy | 17/07/17–19/06/10 | 23/05/03 | 21 sh5 trades | $115.35avg. | $2,422.45 | +1.3% |
UTHR | Open-market sale | 17/10/20–18/12/28 | 23/05/03 | 17 sh4 trades | $111.37avg. | $1,893.29 | −1.0% |